Process View
A slow mechanism of blood pressure regulation that responds to changes in pressure resulting from fluid and salt intake by modulating the quantity of blood in the circulatory system.

In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "renal system process involved in regulation of blood volume"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CAV1 | caveolin 1, caveolae protein, 22kDa | 0.995 | ||
| AXL | AXL receptor tyrosine kinase | 0.964 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.912 | ||
| PDGFRB | platelet-derived growth factor receptor, beta polypeptide | 0.549 | ||
| COL6A1 | collagen, type VI, alpha 1 | 0.425 | ||
| SH3GL3 | SH3-domain GRB2-like 3 | 0.389 | ||
| LGALS1 | lectin, galactoside-binding, soluble, 1 | 0.357 | ||
| DPYSL4 | dihydropyrimidinase-like 4 | 0.260 | ||
| PDGFA | platelet-derived growth factor alpha polypeptide | 0.257 | ||
| ADORA2A | adenosine A2a receptor | 0.169 | ||
| CYP4F2 | cytochrome P450, family 4, subfamily F, polypeptide 2 | 0.124 | ||
| TIMP1 | TIMP metallopeptidase inhibitor 1 | 0.097 | ||
| PTRF | polymerase I and transcript release factor | 0.093 | ||
| COL5A1 | collagen, type V, alpha 1 | 0.092 | ||
| FXYD5 | FXYD domain containing ion transport regulator 5 | 0.092 | ||
| COL4A1 | collagen, type IV, alpha 1 | 0.085 | ||
| CAV2 | caveolin 2 | 0.073 | ||
| CD99 | CD99 molecule | 0.070 | ||
| PDGFC | platelet derived growth factor C | 0.063 | ||
| CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 | 0.058 | ||
| CYP4F3 | cytochrome P450, family 4, subfamily F, polypeptide 3 | 0.057 | Human | |
| SH3BGRL3 | SH3 domain binding glutamic acid-rich protein like 3 | 0.056 | ||
| PRKCDBP | protein kinase C, delta binding protein | 0.056 | ||
| S100A4 | S100 calcium binding protein A4 | 0.054 | ||
| VEGFA | vascular endothelial growth factor A | 0.054 | ||
| S100A6 | S100 calcium binding protein A6 | 0.051 | ||
| CYP4F11 | cytochrome P450, family 4, subfamily F, polypeptide 11 | 0.047 | Human | |
| CAPG | capping protein (actin filament), gelsolin-like | 0.044 | ||
| PROCR | protein C receptor, endothelial | 0.038 | ||
| ANXA5 | annexin A5 | 0.037 | ||
| SRPX | sushi-repeat containing protein, X-linked | 0.036 | ||
| TSPAN4 | tetraspanin 4 | 0.036 | ||
| CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 0.036 | ||
| CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 | 0.036 | ||
| SULT1B1 | sulfotransferase family, cytosolic, 1B, member 1 | 0.034 | ||
| TMSB10 | thymosin beta 10 | 0.033 | ||
| COL6A2 | collagen, type VI, alpha 2 | 0.032 | ||
| S100A11 | S100 calcium binding protein A11 | 0.032 | ||
| CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 0.032 | ||
| MDFI | MyoD family inhibitor | 0.032 | ||
| COL2A1 | collagen, type II, alpha 1 | 0.031 | ||
| SH3GL1 | SH3-domain GRB2-like 1 | 0.030 | ||
| PLCG1 | phospholipase C, gamma 1 | 0.029 | ||
| COL1A1 | collagen, type I, alpha 1 | 0.029 | ||
| CD97 | CD97 molecule | 0.028 | ||
| CYP4F12 | cytochrome P450, family 4, subfamily F, polypeptide 12 | 0.028 | Human | |
| DAO | D-amino-acid oxidase | 0.028 | ||
| TAGLN2 | transgelin 2 | 0.027 | ||
| CYP3A5 | cytochrome P450, family 3, subfamily A, polypeptide 5 | 0.027 | ||
| PLP2 | proteolipid protein 2 (colonic epithelium-enriched) | 0.026 | ||
| ID1 | inhibitor of DNA binding 1, dominant negative helix-loop-helix protein | 0.026 | ||
| TENC1 | tensin like C1 domain containing phosphatase (tensin 2) | 0.025 | ||
| S100A10 | S100 calcium binding protein A10 | 0.024 | ||
| NBL1 | neuroblastoma, suppression of tumorigenicity 1 | 0.024 | ||
| THBS1 | thrombospondin 1 | 0.024 | ||
| HTRA1 | HtrA serine peptidase 1 | 0.023 | ||
| COL1A2 | collagen, type I, alpha 2 | 0.022 | ||
| MAT1A | methionine adenosyltransferase I, alpha | 0.022 | ||
| PRLR | prolactin receptor | 0.021 | ||
| COL4A2 | collagen, type IV, alpha 2 | 0.021 | ||
| IGFBP6 | insulin-like growth factor binding protein 6 | 0.021 | ||
| ANXA6 | annexin A6 | 0.019 | ||
| CSRP1 | cysteine and glycine-rich protein 1 | 0.019 | ||
| KNG1 | kininogen 1 | 0.019 | ||
| GJA1 | gap junction protein, alpha 1, 43kDa | 0.019 | ||
| ROM1 | retinal outer segment membrane protein 1 | 0.019 | ||
| LMNA | lamin A/C | 0.019 | ||
| IFITM2 | interferon induced transmembrane protein 2 (1-8D) | 0.018 | ||
| TGFBI | transforming growth factor, beta-induced, 68kDa | 0.018 | ||
| CYP4B1 | cytochrome P450, family 4, subfamily B, polypeptide 1 | 0.018 | Human | |
| AZGP1 | alpha-2-glycoprotein 1, zinc-binding | 0.018 | ||
| DIO1 | deiodinase, iodothyronine, type I | 0.017 | ||
| RIMS3 | regulating synaptic membrane exocytosis 3 | 0.016 | ||
| PAH | phenylalanine hydroxylase | 0.016 | ||
| LAMB2 | laminin, beta 2 (laminin S) | 0.016 | ||
| SLC22A1 | solute carrier family 22 (organic cation transporter), member 1 | 0.016 | ||
| HAL | histidine ammonia-lyase | 0.016 | ||
| VIM | vimentin | 0.016 | ||
| EPHX2 | epoxide hydrolase 2, cytoplasmic | 0.016 | ||
| ENG | endoglin | 0.016 | ||
| SULT1E1 | sulfotransferase family 1E, estrogen-preferring, member 1 | 0.016 | ||
| OSGIN1 | oxidative stress induced growth inhibitor 1 | 0.016 | ||
| MGP | matrix Gla protein | 0.016 | ||
| GFER | growth factor, augmenter of liver regeneration | 0.016 | ||
| CD63 | CD63 molecule | 0.016 | ||
| C20orf4 | chromosome 20 open reading frame 4 | 0.015 | ||
| PTPRF | protein tyrosine phosphatase, receptor type, F | 0.015 | ||
| EDNRB | endothelin receptor type B | 0.015 | ||
| LRP1 | low density lipoprotein receptor-related protein 1 | 0.015 | ||
| CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 | 0.015 | ||
| UNC5B | unc-5 homolog B (C. elegans) | 0.015 | ||
| ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | 0.015 | ||
| EHD2 | EH-domain containing 2 | 0.015 | ||
| CFD | complement factor D (adipsin) | 0.015 | ||
| PTEN | phosphatase and tensin homolog | 0.015 | ||
| PLAT | plasminogen activator, tissue | 0.015 | ||
| ADH6 | alcohol dehydrogenase 6 (class V) | 0.015 | ||
| S100A13 | S100 calcium binding protein A13 | 0.015 | ||
| CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 | 0.015 | ||
| AADAC | arylacetamide deacetylase (esterase) | 0.015 | ||
| EMP1 | epithelial membrane protein 1 | 0.014 | ||
| DRD1 | dopamine receptor D1 | 0.014 | ||
| ZCCHC24 | zinc finger, CCHC domain containing 24 | 0.014 | ||
| PLG | plasminogen | 0.014 | ||
| DPYS | dihydropyrimidinase | 0.014 | ||
| NRP1 | neuropilin 1 | 0.014 | ||
| CLDN8 | claudin 8 | 0.014 | ||
| ANXA2 | annexin A2 | 0.014 | ||
| DBH | dopamine beta-hydroxylase (dopamine beta-monooxygenase) | 0.014 | ||
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.014 | ||
| SERPINF1 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1 | 0.014 | ||
| MCAM | melanoma cell adhesion molecule | 0.014 | ||
| TXNRD1 | thioredoxin reductase 1 | 0.014 | ||
| CYP2C18 | cytochrome P450, family 2, subfamily C, polypeptide 18 | 0.014 | ||
| AKR1C4 | aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4) | 0.014 | ||
| SCNN1B | sodium channel, nonvoltage-gated 1, beta | 0.014 | ||
| UGT1A3 | UDP glucuronosyltransferase 1 family, polypeptide A3 | 0.014 | ||
| FABP2 | fatty acid binding protein 2, intestinal | 0.014 | ||
| SULT2B1 | sulfotransferase family, cytosolic, 2B, member 1 | 0.014 | ||
| PLEKHG6 | pleckstrin homology domain containing, family G (with RhoGef domain) member 6 | 0.014 | ||
| RDH16 | retinol dehydrogenase 16 (all-trans) | 0.014 | ||
| COL6A3 | collagen, type VI, alpha 3 | 0.013 | ||
| SULT2A1 | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | 0.013 | ||
| TRPV2 | transient receptor potential cation channel, subfamily V, member 2 | 0.013 | ||
| MYLK | myosin light chain kinase | 0.013 | ||
| FABP1 | fatty acid binding protein 1, liver | 0.013 | ||
| RAB34 | RAB34, member RAS oncogene family | 0.013 | ||
| IFITM3 | interferon induced transmembrane protein 3 (1-8U) | 0.013 | ||
| CYP4F8 | cytochrome P450, family 4, subfamily F, polypeptide 8 | 0.013 | Human | |
| C8B | complement component 8, beta polypeptide | 0.013 | ||
| SDPR | serum deprivation response | 0.013 | ||
| DEFB1 | defensin, beta 1 | 0.013 | ||
| SERPING1 | serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 | 0.013 | ||
| CLIC1 | chloride intracellular channel 1 | 0.013 | ||
| PIPOX | pipecolic acid oxidase | 0.013 | ||
| BHMT | betaine--homocysteine S-methyltransferase | 0.013 | ||
| PPFIA4 | protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4 | 0.013 | ||
| TINAGL1 | tubulointerstitial nephritis antigen-like 1 | 0.013 | ||
| SLC38A3 | solute carrier family 38, member 3 | 0.013 | ||
| GPT | glutamic-pyruvate transaminase (alanine aminotransferase) | 0.013 | ||
| CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.013 | ||
| FUT6 | fucosyltransferase 6 (alpha (1,3) fucosyltransferase) | 0.013 | ||
| SYT12 | synaptotagmin XII | 0.013 | ||
| SCNN1A | sodium channel, nonvoltage-gated 1 alpha | 0.013 | ||
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.013 | ||
| ABCC3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | 0.013 | ||
| GLYAT | glycine-N-acyltransferase | 0.013 | ||
| HPN | hepsin | 0.013 | ||
| SEC14L2 | SEC14-like 2 (S. cerevisiae) | 0.012 | ||
| TMEM40 | transmembrane protein 40 | 0.012 | ||
| COL16A1 | collagen, type XVI, alpha 1 | 0.012 | ||
| MPZL2 | myelin protein zero-like 2 | 0.012 | ||
| G6PC | glucose-6-phosphatase, catalytic subunit | 0.012 | ||
| FETUB | fetuin B | 0.012 | ||
| MASP2 | mannan-binding lectin serine peptidase 2 | 0.012 | ||
| ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.012 | ||
| SERPINE1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 0.012 | ||
| SPARC | secreted protein, acidic, cysteine-rich (osteonectin) | 0.012 | ||
| ADH1C | alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.012 | ||
| FLT1 | fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) | 0.012 | ||
| CRYL1 | crystallin, lambda 1 | 0.012 | ||
| VTCN1 | V-set domain containing T cell activation inhibitor 1 | 0.012 | ||
| MT1H | metallothionein 1H | 0.012 | ||
| CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.012 | ||
| IL22RA1 | interleukin 22 receptor, alpha 1 | 0.012 | ||
| SERPINA6 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 | 0.012 | ||
| SLC17A1 | solute carrier family 17 (sodium phosphate), member 1 | 0.012 | ||
| CRX | cone-rod homeobox | 0.012 | ||
| AGXT | alanine-glyoxylate aminotransferase | 0.012 | ||
| PKDREJ | polycystic kidney disease (polycystin) and REJ homolog (sperm receptor for egg jelly homolog, sea urchin) | 0.012 | ||
| FILIP1L | filamin A interacting protein 1-like | 0.012 | ||
| CYP1A2 | cytochrome P450, family 1, subfamily A, polypeptide 2 | 0.012 | ||
| PPAP2B | phosphatidic acid phosphatase type 2B | 0.012 | ||
| TM4SF5 | transmembrane 4 L six family member 5 | 0.012 | ||
| TGFB1I1 | transforming growth factor beta 1 induced transcript 1 | 0.012 | ||
| AKR1D1 | aldo-keto reductase family 1, member D1 (delta 4-3-ketosteroid-5-beta-reductase) | 0.012 | ||
| CYP3A7 | cytochrome P450, family 3, subfamily A, polypeptide 7 | 0.012 | ||
| HAO1 | hydroxyacid oxidase (glycolate oxidase) 1 | 0.012 | ||
| ARG1 | arginase, liver | 0.012 | ||
| GBA3 | glucosidase, beta, acid 3 (cytosolic) | 0.012 | ||
| NPR1 | natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) | 0.011 | ||
| LYPD3 | LY6/PLAUR domain containing 3 | 0.011 | ||
| PTPRN | protein tyrosine phosphatase, receptor type, N | 0.011 | ||
| VEGFC | vascular endothelial growth factor C | 0.011 | ||
| GSTA3 | glutathione S-transferase alpha 3 | 0.011 | ||
| YBX2 | Y box binding protein 2 | 0.011 | ||
| TRAM2 | translocation associated membrane protein 2 | 0.011 | ||
| EVC2 | Ellis van Creveld syndrome 2 | 0.011 | ||
| C4BPA | complement component 4 binding protein, alpha | 0.011 | ||
| SLC13A2 | solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | 0.011 | ||
| C9 | complement component 9 | 0.011 | ||
| PIP | prolactin-induced protein | 0.011 | ||
| CES1 | carboxylesterase 1 | 0.011 | ||
| SLC12A3 | solute carrier family 12 (sodium/chloride transporters), member 3 | 0.011 | ||
| HAO2 | hydroxyacid oxidase 2 (long chain) | 0.011 | ||
| ECM1 | extracellular matrix protein 1 | 0.011 | ||
| GSTT1 | glutathione S-transferase theta 1 | 0.011 | ||
| TRPV4 | transient receptor potential cation channel, subfamily V, member 4 | 0.011 | ||
| SERPINC1 | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 0.011 | ||
| CPB2 | carboxypeptidase B2 (plasma) | 0.011 | ||
| FCN2 | ficolin (collagen/fibrinogen domain containing lectin) 2 (hucolin) | 0.011 | ||
| COL3A1 | collagen, type III, alpha 1 | 0.011 | ||
| PROC | protein C (inactivator of coagulation factors Va and VIIIa) | 0.011 | ||
| MT1F | metallothionein 1F | 0.011 | ||
| CA9 | carbonic anhydrase IX | 0.011 | ||
| LGALS3 | lectin, galactoside-binding, soluble, 3 | 0.011 | ||
| IL1RL2 | interleukin 1 receptor-like 2 | 0.011 | ||
| CYP17A1 | cytochrome P450, family 17, subfamily A, polypeptide 1 | 0.011 | ||
| HSD3B2 | hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 2 | 0.011 | ||
| ALDH1L1 | aldehyde dehydrogenase 1 family, member L1 | 0.011 | ||
| CA5A | carbonic anhydrase VA, mitochondrial | 0.011 | ||
| FCGRT | Fc fragment of IgG, receptor, transporter, alpha | 0.011 | ||
| ETNK2 | ethanolamine kinase 2 | 0.011 | ||
| ADRA1A | adrenergic, alpha-1A-, receptor | 0.011 | ||
| BST1 | bone marrow stromal cell antigen 1 | 0.011 | ||
| S100A14 | S100 calcium binding protein A14 | 0.011 | ||
| DRD2 | dopamine receptor D2 | 0.011 | ||
| GNG11 | guanine nucleotide binding protein (G protein), gamma 11 | 0.011 | ||
| PTPRB | protein tyrosine phosphatase, receptor type, B | 0.011 | ||
| CLCN2 | chloride channel 2 | 0.011 | ||
| PARVA | parvin, alpha | 0.011 | ||
| CD44 | CD44 molecule (Indian blood group) | 0.011 | ||
| SLC13A3 | solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3 | 0.011 | ||
| N4BP3 | NEDD4 binding protein 3 | 0.011 | ||
| ZNF707 | zinc finger protein 707 | 0.011 | ||
| NID1 | nidogen 1 | 0.011 | ||
| KLKB1 | kallikrein B, plasma (Fletcher factor) 1 | 0.011 | ||
| HR | hairless homolog (mouse) | 0.011 | ||
| CPS1 | carbamoyl-phosphate synthase 1, mitochondrial | 0.011 | ||
| LTBP2 | latent transforming growth factor beta binding protein 2 | 0.011 | ||
| C3 | complement component 3 | 0.011 | ||
| CRHBP | corticotropin releasing hormone binding protein | 0.011 | ||
| CYP1A1 | cytochrome P450, family 1, subfamily A, polypeptide 1 | 0.011 | ||
| LTBP4 | latent transforming growth factor beta binding protein 4 | 0.011 | ||
| PLA2G4F | phospholipase A2, group IVF | 0.011 | ||
| PNLIPRP1 | pancreatic lipase-related protein 1 | 0.010 | ||
| TTPA | tocopherol (alpha) transfer protein | 0.010 | ||
| ACSM5 | acyl-CoA synthetase medium-chain family member 5 | 0.010 | ||
| SERPINF2 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | 0.010 | ||
| VTN | vitronectin | 0.010 | ||
| MARK1 | MAP/microtubule affinity-regulating kinase 1 | 0.010 | ||
| DLC1 | deleted in liver cancer 1 | 0.010 | ||
| EVX1 | even-skipped homeobox 1 | 0.010 | ||
| APOH | apolipoprotein H (beta-2-glycoprotein I) | 0.010 | ||
| SEMA3F | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F | 0.010 | ||
| FSTL3 | follistatin-like 3 (secreted glycoprotein) | 0.010 | ||
| SPHK1 | sphingosine kinase 1 | 0.010 | ||
| GPR12 | G protein-coupled receptor 12 | 0.010 | ||
| SLC34A1 | solute carrier family 34 (sodium phosphate), member 1 | 0.010 | ||
| CYP2C8 | cytochrome P450, family 2, subfamily C, polypeptide 8 | 0.010 | ||
| PODXL | podocalyxin-like | 0.010 | ||
| INHBB | inhibin, beta B | 0.010 | ||
| PTPRH | protein tyrosine phosphatase, receptor type, H | 0.010 | ||
| TMPRSS2 | transmembrane protease, serine 2 | 0.010 | ||
| PCK1 | phosphoenolpyruvate carboxykinase 1 (soluble) | 0.010 | ||
| SERPINA10 | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10 | 0.010 | ||
| IGFBP5 | insulin-like growth factor binding protein 5 | 0.010 | ||
| RDH5 | retinol dehydrogenase 5 (11-cis/9-cis) | 0.010 | ||
| TEK | TEK tyrosine kinase, endothelial | 0.010 | ||
| SLC6A12 | solute carrier family 6 (neurotransmitter transporter, betaine/GABA), member 12 | 0.010 | ||
| PRODH2 | proline dehydrogenase (oxidase) 2 | 0.010 | ||
| CYP8B1 | cytochrome P450, family 8, subfamily B, polypeptide 1 | 0.010 | ||
| CYP2A6 | cytochrome P450, family 2, subfamily A, polypeptide 6 | 0.010 | ||
| GPRC5A | G protein-coupled receptor, family C, group 5, member A | 0.010 | ||
| WISP2 | WNT1 inducible signaling pathway protein 2 | 0.010 | ||
| HPD | 4-hydroxyphenylpyruvate dioxygenase | 0.010 |